{"Symbol": "EW", "AssetType": "Common Stock", "Name": "Edwards Lifesciences Corp", "Description": "Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.", "CIK": "1099800", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "MEDICAL DEVICES", "Address": "ONE EDWARDS WAY, IRVINE, CA, UNITED STATES, 92614", "OfficialSite": "https://www.edwards.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-12-31", "MarketCapitalization": "44543279000", "EBITDA": "1788067000", "PERatio": "41.92", "PEGRatio": "2.858", "BookValue": "17.57", "DividendPerShare": "None", "DividendYield": "None", "EPS": "1.81", "RevenuePerShareTTM": "10.38", "ProfitMargin": "0.177", "OperatingMarginTTM": "0.236", "ReturnOnAssetsTTM": "0.0772", "ReturnOnEquityTTM": "0.104", "RevenueTTM": "6067600000", "GrossProfitTTM": "4733400000", "DilutedEPSTTM": "1.81", "QuarterlyEarningsGrowthYOY": "-0.761", "QuarterlyRevenueGrowthYOY": "0.133", "AnalystTargetPrice": "96.5", "AnalystRatingStrongBuy": "5", "AnalystRatingBuy": "16", "AnalystRatingHold": "12", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "41.92", "ForwardPE": "26.45", "PriceToSalesRatioTTM": "7.34", "PriceToBookRatio": "4.314", "EVToRevenue": "6.74", "EVToEBITDA": "24.99", "Beta": "0.94", "52WeekHigh": "87.89", "52WeekLow": "65.94", "50DayMovingAverage": "83.36", "200DayMovingAverage": "79.58", "SharesOutstanding": "580300000", "SharesFloat": "578507000", "PercentInsiders": "0.926", "PercentInstitutions": "90.163", "DividendDate": "None", "ExDividendDate": "None"}